$5.11
-0.25-4.66%
At close: Jul 10, 5:00 PM EST
$5.33
0.224.34%
After Hours: Jul 10, 9:29 AM EST
Immuneering Corp Earnings Estimates
IMRXNASDAQ
Immuneering Earnings Estimates, EPS & Revenue | NASDAQ:IMRX
Immuneering (IMRX) is scheduled to report Q2 earnings on August 12, 2026. Analysts estimate EPS of $-0.27 and quarterly revenue of N/A.
In the most recent quarter (Q1), Immuneering reported EPS of $-0.21, beating estimates of $-0.26 by 0.19%. Revenue came in at $0, meeting the estimate of $0 by 0.00%.
Immuneering has beaten EPS estimates in 2 consecutive quarters.
Over the last 4 quarters, Immuneering has averaged an EPS surprise of 0.15% and a revenue surprise of 0.00%.
Earnings Date
Aug 12
EPS Estimate
$-0.270
Quarterly Revenue Estimate
–
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
Immuneering Earnings History
Analyze the earnings history of Immuneering using advanced sorting and filters.
Loading calendar...
Immuneering (IMRX) Earnings Per Share
The chart below shows Immuneering's reported EPS compared to analyst estimates over recent quarters.
Immuneering (IMRX) Revenue
The chart below shows Immuneering's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Immuneering (NASDAQ:IMRX) reporting earnings?
Immuneering (IMRX) is scheduled to report earnings on August 12, 2026. The last reported earnings were for reported on May 15, 2026 for Q1.
What were the latest earnings per share (EPS) for Immuneering (NASDAQ:IMRX)?
The Actual EPS was $-0.21, which beat the estimate of $-0.26.
What were Immuneering’s (NASDAQ:IMRX) revenues?
The Actual Revenue was $0, which hit the estimate of $0.
